Riskpilot← Back to searchSign inGet full accessARKEN DYREKLINIKK AS
ASActiveOrg 923659803Industriveien 8, 4331 ÅlgårdVeterinary activities · NACE 7500Est. 201917 employees
Revenue 2024
NOK 19M
-5% vs 2023
EBITDA margin
0.5%
-97% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
NOK -320K
-115% vs 2023
| Revenue | NOK 19M | -5% |
| EBITDA | NOK 90K | -97% |
| Net profit | NOK -320K | -115% |
| Total assets | NOK 7,2M | -11% |
| Equity | NOK 4,2M | -6% |
| Employees | 17 | — |
Legal name
ARKEN DYREKLINIKK AS
Org number
923659803
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
22. oktober 2019
Share capital
NOK 30 000
Employees
17 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Veterinærtjenester og dyreklinikk, samt kjøp og salg av varer tilpasset denne virksomheten.
Address
Industriveien 8, 4331 Ålgård
Phone
+4751219700
Email
post@arkendyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 102 | 16 085 | 16 825 | 20 067 | 19 038 |
| Staff expenses | −5 295 | −7 378 | −7 178 | −9 847 | −10 659 |
| EBITDA | 3 408 | 3 132 | 4 320 | 3 031 | 90 |
| Depreciation & amort. | −120 | −296 | −305 | −425 | −546 |
| EBIT | 3 289 | 2 836 | 4 015 | 2 606 | −456 |
| Net financials | −3 | −1 | 7 | 48 | 61 |
| Profit before tax | 3 286 | 2 835 | 4 022 | 2 654 | −395 |
| Tax | 855 | 624 | 885 | 584 | −75 |
| Net profit | 2 431 | 2 211 | 3 137 | 2 069 | −320 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 297 | 5 766 | 8 383 | 8 101 | 7 240 |
| Equity | 218 | 1 913 | 2 869 | 4 438 | 4 175 |
| Long-term debt | 163 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 917 | 3 852 | 5 509 | 3 663 | 3 065 |
| Total debt | 8 080 | 3 852 | 5 515 | 3 663 | 3 065 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20202024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
-7.7%
This company
18.4%
Market median
-142% vs market
20202024
Net profit margin
-1.7%
This company
8.1%
Market median
-121% vs market
20202024
Asset turnover
2.63×
This company
1.12×
Market median
+135% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
As-Ma Holding As
ARKEN DYREKLINIKK AS Board members of ARKEN DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Sofie Winsløw Stie-Welsh | Chief Executive Officer | 0 companies |
| Mark Andrew Welsh | Chairman | 0 companies |